Profile: Covalon Technologies Ltd (COV.V)

COV.V on TSX Venture Exchange

2.36CAD
21 Aug 2014
Price Change (% chg)

$0.01 (+0.43%)
Prev Close
$2.35
Open
$2.36
Day's High
$2.36
Day's Low
$2.36
Volume
300
Avg. Vol
16,404
52-wk High
$2.98
52-wk Low
$0.26

Search Stocks
Covalon Technologies Ltd. (Covalon) is a medical device and biotechnology commercialization company. The Company is engaged in the business of developing, licensing and selling medical technologies. The Company operates in two segments: Advanced Wound Care and Specialized Medical Device Coatings. Its offices and laboratories are located in Mississauga, Ontario, Canada. Covalon sells its technologies to medical companies and distributors. Covalon’s antimicrobial technologies can be used for applications in areas, such as medical device coatings, wound care products, polymer mixes for extrusion, skin sanitizers, surface sanitizers, cosmetics, consumer products, veterinary applications, and others. Its products include ColActive, ColActive Ag, ColActive Plus, ColActive Plus Ag and CovaClear Ag. The Company’s wholly owned subsidiaries include Covalon Technologies Inc. and COV Healthcare Innovations Corp.

Company Address

Covalon Technologies Ltd

Suite 106, 405 Britannia Road Ea
MISSISSAUGA   ON   L4Z 3E6
P: +1905.5688400
F: +1905.5685200

Search Stocks